Mean wheal size from peanut prick skin and IgE levels in peanut allergic patients receiving oral peanut immunotherapy

被引:0
|
作者
Adair, M. A. [1 ]
Laubach, S. S. [1 ]
Steele, P. [1 ]
Kamilaris, J. [1 ]
Pons, L. [1 ]
Kulis, M. [1 ]
Scurlock, A. M. [2 ]
Jones, S. M. [2 ]
Burks, A. W. [1 ]
机构
[1] Duke Univ, Durham, NC 27706 USA
[2] Arkansas Childrens Hosp, Little Rock, AR 72202 USA
关键词
D O I
10.1016/j.jaci.2007.12.542
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
527
引用
收藏
页码:S136 / S136
页数:1
相关论文
共 50 条
  • [41] Transitioning from epicutaneous to oral peanut immunotherapy
    Wong, Lauren
    Kost, Laurie
    Anderson, Brent
    Long, Andrew
    Sindher, Sayantani B.
    Chinthrajah, R. Sharon
    Collins, William J.
    FRONTIERS IN ALLERGY, 2023, 4
  • [42] ASSOCIATION OF GENETIC VARIANTS OF CD14 WITH PEANUT ALLERGY AND ELEVATED IgE LEVELS IN PEANUT ALLERGIC INDIVIDUALS
    Dreskin, Stephen C.
    Ayars, Andrew
    Jin, Ying
    Atkins, Dan
    Leo, Harvey L.
    Song, Benjamin
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2011, 106 (02) : 170 - 172
  • [43] Low-dose peanut challenges can facilitate infant peanut introduction regardless of skin prick test size
    Lin, Adora
    Uygungil, Burcin
    Robbins, Karen
    Ackerman, Olivia
    Sharma, Hemant
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2020, 125 (01) : 97 - 99
  • [44] Plasma from Subjects on Peanut Oral Immunotherapy (OIT) Suppresses ex vivo Basophil Activation in Peanut-Allergic Subjects
    Burk, C.
    Kulis, M.
    Kamilaris, N.
    Chin, S.
    Burks, A. W.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2012, 129 (02) : AB65 - AB65
  • [45] Evidence of pathway-specific basophil anergy induced by peanut oral immunotherapy in peanut-allergic children
    Thyagarajan, A.
    Jones, S. M.
    Calatroni, A.
    Pons, L.
    Kulis, M.
    Woo, C. S.
    Kamalakannan, M.
    Vickery, B. P.
    Scurlock, A. M.
    Burks, A. Wesley
    Shreffler, W. G.
    CLINICAL AND EXPERIMENTAL ALLERGY, 2012, 42 (08): : 1197 - 1205
  • [46] Allergic reaction after accidental peanut exposure in a randomized, placebo-controlled trial on peanut oral immunotherapy
    Trendelenburg, V
    Bluemchen, K.
    Ahrens, F.
    Gruebel, A.
    Hamelmann, E.
    Hansen, G.
    Heinzmann, A.
    Nemat, K.
    Holzhauser, T.
    Roeder, M.
    Rosenfeld, L.
    Hartmann, O.
    Niggemann, B.
    Beyer, K.
    ALLERGY, 2019, 74 : 303 - 303
  • [47] Effect of Peanut Oral Immunotherapy (OIT) on Other Food Allergen-Specific IgE Levels
    Bird, J. A.
    Kulis, M.
    Kamilaris, N.
    Varshney, P.
    Pons, L.
    Vickery, B.
    Burks, A. W.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2011, 127 (02) : AB25 - AB25
  • [48] Do Age and Baseline Peanut-specific IgE Levels Predict Oral Immunotherapy Outcomes?
    Guarnieri, Katharine
    Slack, Ian
    Eapen, Amy
    Gadoury-Levesque, Vanessa
    Andorf, Sandra
    Lierl, Michelle
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2021, 147 (02) : AB105 - AB105
  • [49] Changes in peanut and peanut allergen component immunoglobulin G4 levels over time in children with peanut allergy treated with peanut oral immunotherapy during the palisade trial
    Nilsson, C.
    Vereda, A.
    Borres, M.
    Sodergren, E.
    Rudengren, M.
    Fernandez-Rivas, M.
    ALLERGY, 2023, 78 : 172 - 173
  • [50] Accidental reactions to peanut occur despite peanut oral immunotherapy: A report from the BRIT registry
    Dawson, Tom
    Villa, Luciano Perfetti
    Maslovskaya, Olga
    Brathwaite, Nicola
    Chapman, John
    Du Toit, George
    Fox, Adam
    Gardner, James
    Ivanova, Aneta
    Leech, Sue
    Noimark, Lee
    Sheikh, Shifa
    Smith, Maria
    Baker, Sarah
    Khan, Sujoy
    Marriage, Deborah
    Michaelis, Louise
    Ozygit, Leyla Pur
    Thursby-Pelham, Anna
    Warner, Amena
    Lajeurnesse, Mich
    CLINICAL AND EXPERIMENTAL ALLERGY, 2024, 54 (10): : 843 - 844